This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.

Inclusion Criteria:

• Aged 35-54, male or female
• Regular alcohol consumption
• Event planned within one month that involves alcohol consumption
• Willingness to avoid new medications or supplements during the study period
• Must confirm that they will not drive while under the influence of alcohol.

Exclusion Criteria:

• Anyone not in good health.
• Anyone who has any chronic health conditions such as oncological or psychiatric disorders.
• Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
• Anyone who is pregnant, breastfeeding, or trying to conceive.
• Anyone who cannot/ will not commit to the study protocol.
• Anyone with a history of substance abuse.
• Anyone who has undergone an invasive medical procedure in the six months prior to the study, or has a procedure planned during the study duration.
• Anyone currently using any medications that may affect their response to alcohol or impact hangover symptoms, such as diuretics (water pills) or medication for hypertension.
• History of severe reactions or sensitivity to alcohol.
• Anyone currently taking glutathione.

This study uses a double-blind design, meaning that both the participants and the investigators are unaware of the group assignments.